255 related articles for article (PubMed ID: 18575768)
1. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase.
Tsutsumi K; Kasaoka T; Park HM; Nishiyama H; Nakajima M; Honda T
Int J Oncol; 2008 Jul; 33(1):215-24. PubMed ID: 18575768
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
Mitra SK; Lim ST; Chi A; Schlaepfer DD
Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501
[TBL] [Abstract][Full Text] [Related]
3. RNA interference-mediated silencing of focal adhesion kinase inhibits growth of human malignant glioma xenograft in nude mice.
Wang GJ; Ma YP; Yang Y; Zhang N; Wang W; Liu SY; Chen LJ; Jiang Y; Zhao X; Wei YQ; Deng HX
Cell Biol Int; 2011 Aug; 35(8):841-8. PubMed ID: 21247411
[TBL] [Abstract][Full Text] [Related]
4. FAK expression regulation and therapeutic potential.
Li S; Hua ZC
Adv Cancer Res; 2008; 101():45-61. PubMed ID: 19055942
[TBL] [Abstract][Full Text] [Related]
5. [RNA interference targeting focal adhesion kinase inhibited the growth of human hepatocellular carcinoma sk-hep-1].
Xu WJ; Zhang S; Zhang N; Yang Y; Wei YQ; Deng HX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):455-60. PubMed ID: 21866625
[TBL] [Abstract][Full Text] [Related]
6. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
[TBL] [Abstract][Full Text] [Related]
7. A role for focal adhesion kinase signaling in tumor necrosis factor-alpha-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1.
Mon NN; Hasegawa H; Thant AA; Huang P; Tanimura Y; Senga T; Hamaguchi M
Cancer Res; 2006 Jul; 66(13):6778-84. PubMed ID: 16818654
[TBL] [Abstract][Full Text] [Related]
8. [The role of FAK expression inhibition by RNA interference on liver cancer cells].
Yuan Z; Zheng Q; Huang XY; Fan J
Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1350-3. PubMed ID: 18241574
[TBL] [Abstract][Full Text] [Related]
9. Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability.
Huang YT; Lee LT; Lee PP; Lin YS; Lee MT
Anticancer Res; 2005; 25(3B):2017-25. PubMed ID: 16158939
[TBL] [Abstract][Full Text] [Related]
10. Disruption of focal adhesion kinase slows transendothelial migration of AU-565 breast cancer cells.
Earley S; Plopper GE
Biochem Biophys Res Commun; 2006 Nov; 350(2):405-12. PubMed ID: 17010315
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs.
Han EK; Mcgonigal T; Wang J; Giranda VL; Luo Y
Anticancer Res; 2004; 24(6):3899-905. PubMed ID: 15736429
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells.
Garces CA; Kurenova EV; Golubovskaya VM; Cance WG
Cancer Res; 2006 Feb; 66(3):1446-54. PubMed ID: 16452200
[TBL] [Abstract][Full Text] [Related]
13. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
Brenner W; Greber I; Gudejko-Thiel J; Beitz S; Schneider E; Walenta S; Peters K; Unger R; Thüroff JW
Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341
[TBL] [Abstract][Full Text] [Related]
14. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation.
Cox BD; Natarajan M; Stettner MR; Gladson CL
J Cell Biochem; 2006 Sep; 99(1):35-52. PubMed ID: 16823799
[TBL] [Abstract][Full Text] [Related]
15. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
[TBL] [Abstract][Full Text] [Related]
16. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y
Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478
[TBL] [Abstract][Full Text] [Related]
17. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase.
Hu XW; Meng D; Fang J
Carcinogenesis; 2008 Dec; 29(12):2369-76. PubMed ID: 18974065
[TBL] [Abstract][Full Text] [Related]
18. Targeting focal adhesion kinase signaling in tumor growth and metastasis.
Schwock J; Dhani N; Hedley DW
Expert Opin Ther Targets; 2010 Jan; 14(1):77-94. PubMed ID: 20001212
[TBL] [Abstract][Full Text] [Related]
19. FAK silencing inhibits leukemogenesis in BCR/ABL-transformed hematopoietic cells.
Le Y; Xu L; Lu J; Fang J; Nardi V; Chai L; Silberstein LE
Am J Hematol; 2009 May; 84(5):273-8. PubMed ID: 19358301
[TBL] [Abstract][Full Text] [Related]
20. Targeting of focal adhesion kinase by small interfering RNAs reduces chondrocyte redifferentiation capacity in alginate beads culture with type II collagen.
Kim YH; Lee JW
J Cell Physiol; 2009 Mar; 218(3):623-30. PubMed ID: 19006177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
